#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute respiratory distress syndrome HER2 gene amplification Desmoid tumour Scedosporium infection Post transplant lymphoproliferative disorder Pseudomyxoma peritonei Metastases to central nervous system Type IIa hyperlipidaemia Familial haemophagocytic lymphohistiocytosis Alexander disease Adrenoleukodystrophy Adenocarcinoma gastric Pelizaeus-Merzbacher disease Myelin oligodendrocyte glycoprotein antibody-associated disease Bone marrow disorder More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Diagnostics Primary biliary cholangitis – Trials in Disease Congenital generalised lipodystrophy – Treatment Haemophilia B with anti factor IX – Treatment Burkitt’s lymphoma – Basic Information Mast cell activation syndrome – Diagnostics Primary hyperoxaluria – Diagnostics Mucopolysaccharidosis I – Life with Disease Alveolar rhabdomyosarcoma – Trials in Disease Rhabdomyosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salbutamol Sulfate Zopiclone Abc-35B-116 REGN7544 L-Lysine Hydrochloride GSKVX000000034794 Nms-03305293 Bempikibart Ambroxol Hydrochloride OMTX705 Prednisone Acetate Doravirine Tremelimumab Nicotine Resinate Dcc-3116 Atacicept Gsk3739937 TALADEGIB Lenvatinib Desonide More therapies…

    Learn about Your Condition

    Implantation complication Urea cycle disorder Laryngeal cancer stage III Lip and/or oral cavity cancer Glioblastoma multiforme T-cell type acute leukaemia EGFR gene mutation Hysterectomy Multiple system atrophy Skin candida PIK3CA-activated mutation Myotonia Food allergy Hepatorenal syndrome Fatty acid oxidation disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Safety and Effects of Orziloben (NST-6179) for Patients with Intestinal Failure-Associated Liver Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Gastrointestinal disorder
    Belgium Denmark France

  • Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Peritonitis
    Investigated Drugs:
    • Fosfomycin
    • Metronidazole
    • Molgramostim
    Denmark

  • Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Sotorasib
    • Panitumumab
    • Fluorouracil
    France Germany Italy Spain

  • Study on Amoxicillin and Potassium Clavulanate for Preventing Anal Fistula in Patients After First Perianal Abscess Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal abscess
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • POTASSIUM CLAVULANATE
    Spain

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • HER2 positive gastric cancer
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Fluorouracil
    • Oxaliplatin
    Austria Germany

  • Study on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Acetylcysteine
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    Spain
Previous Page
1 … 50 51 52 53 54 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!